| J9271 | Injection, pembrolizumab, 1 mg | 8,100 | $40 | $348.3K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,960 | $20 | $43.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 350 | $110 | $37.1K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 230 | $140 | $32.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 270 | $90 | $25.2K |
| J0897 | Injection, denosumab, 1 mg | 1,260 | $20 | $22.7K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 6,800 | $1 | $13.6K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 90 | $130 | $12.5K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 160 | $60 | $9.4K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 50 | $170 | $8.3K |